The use of xenobiotic-mediated methaemoglobin formation to assess the effects of thyroid hormones on diabetic and non-diabetic human erythrocytic oxidant defence mechanisms in vitro

Environmental Toxicology and Pharmacology

Volumn 13, Issue 1, 2003, Pages 15-19

  Coleman, Michael D ^a   Gaskin, Claire A ^a   Fernandes, Sandra ^a   Khanderia, Leena ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Methaemoglobin; Oxidant defence erythrocyte dapsone hydroxylamine; Thyroxine; Triiodothyronine

Indexed keywords

LIOTHYRONINE; METHEMOGLOBIN; N HYDROXYDAPSONE; NITRITE; THYROID HORMONE; THYROXINE; XENOBIOTIC AGENT;

ARTICLE; CELL TYPE; CONTROLLED STUDY; DEFENSE MECHANISM; DIABETES MELLITUS; DRUG EFFECT; ERYTHROCYTE; HORMONE ACTION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPOTHYROIDISM; INCUBATION TIME; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0037210341     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(02)00108-4     Document Type: Article

References (28)

1. Anderson M.E. Determination of GSH and GSH disulfide in biological samples. Meth. Enzymol. 113:1985;549.
2. Blakynty R., Harding J.J. Glycation (non-enzymatic glycosylation) inactivates glutathione reductase. Biochem. J. 288:1992;303.
3. Bravi M.C., Pietrangeli P., Laurenti O., Basili S., Cassone-Faldetta C., Ferri C., De Mattia G. Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. Metabolism. 46:1997;1194.
4. Coleman M.D. `Commentary', the use of in vitro methaemoglobin generation to study antioxidant status in the diabetic erythrocyte. Biochem. Pharmacol. 60:2000;1409.
5. Coleman, M.D., 2001. Monitoring diabetic antioxidant status: a role for in vitro methaemoglobin formation. Environ. Toxicol. Pharmacol. 10, 207.
6. Coleman M.D., Walker C.L. Effects of the antioxidants α-lipoic acid and α-tocopherol on xenobiotic-mediated methaemoglobin formation in human diabetic and non-diabetic erythrocytes in vitro. Environ. Toxicol. Pharmacol. 8:2000;127.
7. Coleman M.D., Baker C.D. Effects of the antioxidants dihydrolipoic acid (DHLA) and probucol on xenobiotic-mediated methaemoglobin formation in human diabetic and non-diabetic erythrocytes in vitro. Environ. Toxicol. Pharmacol. 9:2001;161.
8. Coleman M.D., Simpson J., Jacobus D.P. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro III: effect of diabetes. Biochem. Pharmacol. 48:1994;1341.
9. Coleman M.D., Ogg M.S., Holmes J.L., Gardiner J.M., Jacobus D.P. Studies on the differential sensitivity between diabetic and non-diabetic human erythrocytes to monoacetyl dapsone hydroxylamine-mediated methaemoglobin formation in vitro. Environ. Toxicol. Pharmacol. 1:1996;97.
10. Coleman M.D., Hayes P.J., Jacobus D.P. Methaemoglobin formation due to nitrite, disulfiram, 4-aminophenol and monoacetyldapsone hydroxylamine in diabetic and non-diabetic human erythrocytes in vitro. Environ. Toxicol. Pharmacol. 5:1998;61.
11. Coleman M.D., Eason R.D., Bailey C.J. The therapeutic use of lipoic acid in diabetes: a current perspective. Environ. Toxicol. Pharm. 10:2001;167.
12. Costagliola C. Oxidative state of glutathione in red blood cells and plasma of diabetic patients: in vivo and in vitro study. Clin. Physiol. Biochem. 8:1990;204.
13. 2+-ATPase by thyroid hormone. Biochem. Biophys. Res. Commun. 99:1981;1073.
14. Gupta B., Baquer N.Z. Ageing erythrocytes and alloxan diabetes: II role of thryoxine in reversing diabetic state. Biochem. Molec. Biol. Int. 33:1994;625.
15. Gupta B.L., Ansari M.A., Singh J.N., Baquer N.Z. Effect of insulin and thyroxine on catalase, glutathione-S-transferase, GHS and GSSG in alloxan diabetic rat red cells. Biochem. Int. 27:1992;793.
16. Kumar, P. Clark, M., 1994. In: Clinical Medicine, third ed., Balliere Tindall, pp. 829-852.
17. Lissi E. Autocatalytic oxidation of hemoglobin by nitrite: a possible mechanism. Free Radic. Biol. Med. 24:1998;1535.
18. Mazzanti L., Rabini R.A., Salvolini E., Tesei M., Martarelli D., Venerando B., Curatola G. Sialic acid, diabetes and aging: a study on the erythrocyte membrane. Metabolism. 46:1997;59.
19. Mouradian M.M., Abourizk N. Diabetes mellitus and thyroid disease. Diabetes Care. 6:1983;512.
20. Nagashima K., Onigata K., Yagi H., Kuroume T. Transport of triiodothyronine by erythrocytes from premature and term infants. Biol. Neonate. 64:1993;354.
21. Necheles T., Beutler E. The effect of triiodothyronine on the oxidative metabolism of erythrocytes. I. Cellular studies. J. Clin. Invest. 38:1959;788.
22. Pereira B.L., Fernando P., Costa-Rosa L.F., Safi D.A., Bechara E.J.H., Curi R. Hormonal regulation of superoxide dismutase, catalase and glutathione peroxidase activities in rat macrophages. Biochem. Pharmacol. 50:1995;2093.
23. Perros P., McCrimmon R.J., Shaw G., Frier B.M. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabetic Med. 12:1995;622.
24. 3 in rat tissues. Diabetes. 41:1992;147.
25. Snyder L.M., Neri L.L., Chung S.K., Molinari P.F., Reddy W.F. The variation of glucose metabolism in human erythrocytes in the presence of L-thyroxine. Proc. Soc. Exp. Biol. Med. 138:1971;1.
26. Srivastava S.K., Ansari N.H., Hair G.A., Jaspen J., Rao M.B., Das B. Increased activity of aldose reductase in response to hyperglycaemia. Biochim. Biophys. Acta. 870:1986;302.
27. Yamauchi K., Horiuchi R., Takikawa H. Uptake of 3,5,3′-L-tri-iodothyronine in human erythrocytes. J. Endocrinol. 121:1989;585.
28. Zhao W., Devamanoharan P.S., Varma S.D. Fructose induced deactivation of glucose-6-phosphate dehydrogenase activity and its prevention by pyruvate: inplications for cataract prevention. Free Radic. Res. 29:1998;315.